Skip to main content
Clinical Trials/NCT03713255
NCT03713255
Recruiting
Not Applicable

Analgesic Benefits of the Novel Mid-point Transverse Process to Pleura (MTP) Block for Ambulatory Breast Cancer Surgery: A Randomized Controlled Trial

Ottawa Hospital Research Institute1 site in 1 country150 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Ottawa Hospital Research Institute
Enrollment
150
Locations
1
Primary Endpoint
Postoperative analgesia during the first 24 hours.
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study will compare the analgesic effects of midpoint transverse process to pleura (MTP) block to control as well as thoracic paravertebral block.

Detailed Description

Paravertebral blocks (PVBs) are frequently used for regional anesthesia for breast surgery. Ultrasound-guided paravertebral block is an advanced skill. The needle tip can be difficult to visualize with ultrasound, and the proximity to neurovascular structures as well as the pleura presents a risk of neurovascular injection and pneumothorax respectively. The midpoint transverse-process to pleura (MTP) block incorporates a novel needle endpoint that is technically easier to achieve and more distant from neurovascular structures and the pleura compared to traditional PVB. This study will compare the analgesic effects of MTP block to control and PVB.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English or French Speaking
  • Scheduled for major breast surgery
  • ASA physical status classification I-III
  • BMI \<30kg/m2

Exclusion Criteria

  • Prior ipsilateral breast surgery
  • Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest
  • Contraindications to regional anesthesia
  • Patient refusal of regional technique
  • Chronic pain disorder
  • Chronic opioid use
  • Inability to provide informed consent

Outcomes

Primary Outcomes

Postoperative analgesia during the first 24 hours.

Time Frame: 48 hours

Measured by opioid (equivalents of morphine) consumption and pain scores on a numerical rating scale.

Secondary Outcomes

  • Post-operative quality of recovery during the first 24 hours.(48 hours)

Study Sites (1)

Loading locations...

Similar Trials